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Lysine-rich peptide PATA (TFA-SV40-PATA), for C-terminal conjugation in solution.
The commercially available peptide PKKKRKVG-COOH (obtained deprotected but not purified, 25 mg, 0.0266 mmol) was dissolved in 1 mL of methanol in a glass vial which is then put on an icewater bath. Triethylamine (100 μL) was added followed by ethyl trifluoroacetate (300 μL) whereupon the reaction vessel is sealed and allowed to slowly warm up to r.t. The reaction was complete after 3 days, whereafter it was evaporated to dryness and additionally dried under reduced pressure over night. The protected peptide (2) was then dissolved in 200 μL of dry DMF whereupon HBTU (1.1 eq., 11 mg) and NMM (2 eq., 6 μL) were added stepwise. The reaction was stirred at r.t. for 0.5 h after which time ethylenediamine (1.1 eq., 2 μL) was added and the reaction was left standing for an additional 1 h (solution A). The active linker PATA (2 eq., 11 mg) was dissolved in 200 μL of dry DMF. HBTU (2 eq., 20mg) and NMM (2 eq., 5.8 μL) were then added whereupon the reaction was agitated on a vortex for 0.5 h (solution B). After this time the solutions A and B were mixed together and allowed to react for 2 h at r.t. After evaporation to dryness the target peptide 18 was dissolved in 1 M TEAA pH 6.5 containing 30% acetonitrile (buffer C) and purified by RP HPLC using a linear gradient of buffer D (1 M TEAA pH 6.5 containing 90% of acetonitrile) in C from 60-100% in 30 min (UV-detection at 228 nm). t R = 24.2 min, yield = 3.3 mg, 8% (after HPLC purification). ES-MS, calc m/z (M-H) -1 1645.7, found 1645.8.
5'-Azido-oligonucleotides (for solution synthesis of POCs).
The oligonucleotide on solid support (with a 5'-aminolinker, 0.2 μmol, 6 mg) was placed in a sealed Eppendorf tube. 2(2-Azidoethoxy)ethoxyacetic acid (100 eq., 3.8 mg) was dissolved in DMF (280 μL) and first HBTU (100 eq., 7.6 mg) and then NMM (1230 eq., 27 μL) was added. The tube was sealed and agitated on a vortex for 0.5 h at r.t. The activated acid was then added to the supported aminolinker-oligonucleotide, the tube was sealed, agitated on a vortex at high speed for 2 h, centrifuged, and the solution was carefully removed with a syringe, whereupon 200 μL of DMF was added. The tube was agitated, centrifuged and the solution was removed from the solid support. This type of washing is performed 3 times. Deprotection solution (28% NH 3 (aq), 500 μL) is then added, and left at 55 ºC over night. The tube was centrifuged and the solution was collected with a syringe. Another portion of ammonia was added and the suspension was agitated and centrifuged, whereupon the solution was collected. The combined solutions were evaporated to dryness, dissolved in buffer A and purified by RP-HPLC using a linear gradient of buffer B in A from 0-50% in 20 min, detector at 260 nm, at 50 ºC, t R = 15.0 min, ES-MS, calc (M) 2659, found 2659.
Synthesis of POCs by reaction of a peptide-PATA derivative with a 5'-azido-oligonucleotide, in solution.
The oligonucleotide azide derivative from the procedure above (1 mM, 0.075 μmol) was freeze-dried in a 500 μL Eppendorf tube with a seal. The protected TFA-SV40-PATA (18, 2 eq., 0.15 μmol) was dissolved in 65 μL of tBuOH/H 2 O (1:1) and added to the tube containing the oligonucleotide. Copper sulfate (5 μL, from a stock solution containing 3.6 mg/mL in H 2 O, 1.2 eq., 0.09 μmol) was added and the reaction was gently shaken, whereupon a sodium ascorbate solution (5 μL, from a stock containing 8.9 mg/mL in tBuOH/H 2 O (1:1), 3 eq., 0.225 μmol) was added. The tube was sealed and placed horizontally on a vortex and shaken overnight at r.t. The conjugate was purified by RP-HPLC using 1 M TEAA buffer pH 6.5 containing 30% acetonitrile (buffer C) and a linear gradient of buffer D (1 M TEAA containing 90 % acetonitrile) in C from 20-80% in 45 min, detector at 260 nm. TFA-SV40-LNA (entry 5, Table 1 ): t R = 10.0 min (broad); ES-MS, calc m/z (M) 4307, found 4307.
2.
Spectroscopic data for AcMIF1-L1-azide (see also 19 A 
4.
Preparation of non-activated triple bond-derivatives of oligonucleotides. Commercially available oligonucleotide (LNA-Am5) on solid support possessing at 5'-aminolinker with free amino function (0.2 μmol, 3 mg) was placed in sealed Eppendorf tube. Pentynoic acid (100 eq., 1.9 mg) is dissolved in DMF (280 μL) and HBTU (100 eq., 7.6 mg) was added followed by NMM (1230 eq., 27 μL). The tube was sealed and agitated on a vortex for 0.5 h at r.t.. The activated acid was then added to the oligonucleotide on solid support, the tube was sealed and the reaction was agitated on a vortex at high speed for 2 h. The tube was then centrifuged and the solution was carefully removed by a syringe whereupon 200 μL of DMF is added. The tube was vortexed, centrifuged and the supernatant was removed. This type of washing was performed 3 times. Ammonia (28% NH 3 (aq), 500 μL) was added, and deprotection was carried out in a sealed Eppendorf tube at 55 °C overnight. The Tube was centrifuged and the solution was carefully collected with a syringe. Another portion of ammonia solution was added and the suspension was agitated and centrifuged. The combined solutions were evaporated to dryness, dissolved in 50 mM triethylammonium acetate buffer pH 6.5 and purified by RP-HPLC using a linear gradient of buffer B in A from 0-35% in 40 min at 25° C (UV-detection at 260 nm). -Benzotriazole-N,N,N',N'-tetramethyl-uronium-hexafluoro-phosphate , NMM = Nmethyl morpholine, DMF = dimethylformamide.
6.
General Method of the preparation of azido-peptides for C-terminus conjugation (TFA-SV40-L1-azide and SV40-L1-azide).
(A)
Commercially available peptide PKKKRKVG-COOH (1) obtained as deprotected but not purified (25 mg, 0.0266 mmol) is dissolved in 5mL of methanol and put to an ice-bath. Triethylamine is added (100 μL) followed by ethyl trifluoroacetate (300 μL), reaction is sealed and allowed to slowly worm up to r.t.. Reaction is completed after 3 days, evaporated to dryness and additionally dried on vacuum over night. After evaporation to dryness the target peptide TFA-SV40 is dissolved in 50 mM triethylammonium acetate buffer pH 6.5 containing 30% acetonitrile and purified on RP HPLC using linear gradient of buffer B (containing 50% of acetonitrile), detector at 228 nm. 
8.
Synthesis of water soluble C-terminal azide derivatized peptides. The peptides were synthesized like described above, but after the 2h coupling reaction, the mixture was transferred to a glass vial followed by 2 mL of conc. Ammonia (aq), the vial was sealed and kept at 55° C overnight. The solution was then lyophilized, dissolved in the HPLC starting buffer and purified by RP-HPLC, t R = 9.4 min, HPLC purification and analysis was done at 50° C, on a Vydac RP-18 column (218TP510, 10 x 250 mm, 5μmol) using a flow rate of 4 mL/min and first a linear gradient from 15% to 35% aqueous acetonitrile in 40 min followed by 35% to 70% in 10 min (with 0.1% trifluoroacetic acid in all solutions). ESI-MS, calc m/z (M-H) +1 1008.69, found 1008.69. 1-benzyl-1H-1,2,3-triazol-4-yl) methyl]amine. This conjugation was performed as described in the general method for conjugation without ligand except that a tBuOH/DMSO (2:1) solution of [tris [ (1-benzyl-1H-1,2,3-triazol-4-yl) 14.
Synthesis of POCs by conjugation of oligonucleotides on solid support with peptideazides in the presence of [tris [(
Supplementary Figure 5 . Chromatograms of crude reactions of conjugation of 18mer solid supported oligonucleotide with Ac-MIF1-L1-azide; A: using 1 eq. CuI/3eq sodium ascorbate; B: using 1 eq. CuI; C: using 1 eq. CuCl; D: using 1.2 eq. CuSO 4 and 3 eq. of sodium ascorbate. Procedures: CuSO 4 /ascorbate: 4 eq. of peptide-azide (0.316 mg of Ac-MIF1-L2-azide) was dissolved in 80 μL of tBuOH/H 2 O (1:1) and added into the vial. 1.2 eq. of CuSO 4 in 10 μL of H 2 O (from a stock solution of 6 mg/mL) was added to the mixture followed by Na ascorbate solution (3 eq., 0.6 μmol, 10 μL from a stock solution of 12 mg/mL in tBuOH/H 2 O (1:1)) and the solution was agitated on a vortex a low speed at r.t overnight. CuCl: 4 eq. of peptide-azide (0.316 mg of Ac-MIF1-L2-azide) were dissolved in 80 μL of tBuOH/H 2 O (1:1) and added into the vial. 1 eq. of CuCl in 10 μL of DMSO (from a stock solution of 2.2 mg/mL) was added to the mixture followed by DIPEA solution (8 eq., 1.6 μmol, 10 μL from a stock solution of 28 μL in 1 mL of tBuOH/H 2 O (1:1)) and the solution was agitated on a vortex at low speed and at r.t overnight. CuI: The protocol was the same as described above but using 1 eq. of CuI (from a stock solution of 4.3 mg/mL in DMSO) instead of CuCl. CuI/ ascorbate: 4 eq. of peptide-azide (0.316 mg of Ac-MIF1-L2-azide or 1.1 mg of TFA-C-myc-L2-azide) were dissolved in 80 μL of tBuOH/H 2 O (1:1) and added into the vial. The procedure was the same as described above but adding Na ascorbate (3 eq., 0.6 μmol, 10 μL from a stock solution of 12 mg/mL in tBuOH/H 2 O (1:1))
15. 
Supplementary

16.
Estimation of copper content in crude POC preparations using the PAR reagent (4-(2'-Pyridylazo)resorcinol). To a 1 ml sample is added 0.03 ml reagent 4, and the sample is kept for 30 min in 100 C water bath. Then 0.085 ml reagent 5 (NaOH) and 0.05 ml reagent 3 is added. After 3 to 5 min. the absorbance is recorded (400-700 nm). Samples: Blank = 100 μL milliQ-water that is treated the same way as sample. Reference samples: A) 100 μL of drinking water diluted to 1 mL with milliQ water B) 45 μM aqueous (milliQ) CuSO 4 . Samples: Solid supported oligonucleotide-peptide conjugate was after reaction washed with water, acetonitrile, dichloromethane and then dried. C) 1 mg of that prepared support was put directly into a plastic vial, 0.5 mL of aqueous ammonia was added and reaction was kept at 55º C overnight. The vial was centrifuged, the solution collected by a syringe, whereupon the support was washed with water and the solutions were combined and evaporated to dryness.; D) 1mg of washed solid supported oligonucleotide-peptide conjugate was put into a disposable reaction vessel (a syringe with a filter) and washed with 0.05 M EDTA in water (20 mL) after which it was dried and put into plastic vial and treated with ammonia deprotection as for sample C. The respective solutions from C and D were evaporated to dryness and dissolved in 1mL milliQ water. 100 μL was taken out and diluted to 1 mL with milliQ water. 
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